Swiss NBE-Therapeutics chooses WuXi Biologics as manufacturing partner

Chinese-Swiss partnership will focus on development and manufacturing capacity of immune-stimulatory ADC treatment against the ROR1 cancer target

picture of

Breaking News

Kiadis acquires CytoSen for synergistic immunology portfolio

CytoSen Therapeutics develops NK-cell therapy, which complements Kiadis’ T-cell therapy portfolio

Gene therapy uses HIV virus to cure ‘bubble boy’ disease

Therapy has cured 10 infants with no side effects and experts hope this development template will be used for other ...

CPhI North America and iBIO parnership supports women in STEM

Partnership includes US$10,000 donation to fund iBIO STEM programming for girls, plus discounted rates for iBIO members ...

CDMO market trends and dynamics

The rise of the embedded model

CGT Catapult brings SMEs together

Fujifilm Diosynth, Eversheds Sutherland, Mathys & Squire and Stifel gather at CGT Catapult’s first UK Advanced ...

CluePoint champions risk-based study execution

Increased operational efficiency, lower costs and reduced regulatory submission risk are all part of the touted ...

Backend, baffling and buzzing: blockchain

Marco Mohwinckel, healthcare executive and adviser, takes a closer look at the invisible backend technology that has ...

Almac Group further expands global analytical services capability

Almac is investing in additional laboratory space at its Athlone facility in order to support microbiology and GMP ...

Sirio Pharma eyes global R&D collaboration

China's CDMO plans to combine the expertise of its 100+ scientist based in Asia, Europe and the US

Creating the future … together

Based on a principle of co-creation, Corbion collaborates with industry partners to address the biochemical ...

Rare diseases: understanding the patient journey

In the shadow of Rare Disease Day on 28 February 2019, Dr Kevin Robinson met with Zizi Imatorbhebhe, Senior Director of ...

Bacteria as ingredients in skincare products: a manufacturing challenge

The concept of friendly bacteria is now well embedded in the public’s imagination, and various food and drinks ...

Twist Bioscience and LakePharma share resources for antibody platform

Twist will provide its antibody discovery platform, LakePharma will provide development services

Anti-ageing drugs are on the horizon

First-in-human studies have been successfully conducted on patients with pulmonary fibrosis, showing improvements where ...